U.S. SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                 FORM 10-KSB

(MARK ONE)

[X]   ANNUAL REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES
      EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED OCTOBER 27, 2007.

[ ]   TRANSITION REPORT UNDER SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE
      ACT OF 1934 FOR THE TRANSITION PERIOD FROM             TO

                         COMMISSION FILE NUMBER: 0-1455


                            OPT-SCIENCES CORPORATION
                (Name of small business issuer in its charter)

                NEW JERSEY                           21-0681502
      (State or other jurisdiction of               (I.R.S. Employer
       incorporation or organization)              Identification No.)

1912 BANNARD STREET, CINNAMINSON, NEW JERSEY             08077
   Address of principal executive offices)             (Zip Code)



Issuer's telephone number                           (856) 829-2800

Securities registered under Section 12(b) of the Exchange Act: None

Securities registered under Section 12(g) of the Exchange Act:

                   Common Stock, $.25 par value per share
                                (Title of Class)


Check whether the issuer is not required to file reports pursuant to
Section 13 or 15(d) of the Exchange Act.   [  ]


Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days.
YES[X] NO[ ]

Check if there is no disclosure of delinquent filers in response to Item 405
of Regulation S-B contained in this form, and no disclosure will be
contained, to the best of registrant's knowledge, in definitive proxy or
information statements incorporated by reference in Part III of this Form 10-
KSB or any amendment to this Form 10-KSB. [X]

Indicate by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act). YES[ ] NO[X]

State issuer's revenues for its most recent fiscal year: $5,712,810.

The aggregate market value of the 239,945 common shares held by non-
affiliates (i.e. excluding shares held by officers, directors and each person
owning 5% or more of the outstanding stock) on December 31, 2007 was
approximately $2,771,364 based on the average of the bid and asked price of
the stock on that date as quoted by the Pink Sheets, in the non-NASDAQ over
the counter market.

State the number of shares outstanding of each of the issuer's classes of
common equity as of the latest practical date: 775,585 shares of the issuer's
common stock, par value of $.25, were outstanding on December 31, 2007.

Documents Incorporated by Reference: None.

Transitional Small Business Disclosure Format (CHECK ONE): YES[ ] NO[X]

























































                             TABLE OF CONTENTS

                FORM 10-KSB ANNUAL REPORT - FISCAL YEAR 2007
                  OPT-SCIENCES CORPORATION AND SUBSIDIARY

PART I                                                          PAGE

Item 1.  Description of Business...................................4
Item 2.  Description of Property...................................7
Item 3.  Legal Proceedings.........................................7
Item 4.  Submission of Matters to a Vote of Security
         Holders...................................................8

PART II

Item 5.  Market for Common Equity and Related Stockholder
         Matters and Small Business Issuer Purchases
         of Equity Securities......................................8
Item 6.  Management's Discussion and Analysis or Plan of
         Operation.................................................8
Item 7.  Financial Statements.....................................13
Item 8.  Changes In and Disagreements with Accountants
         on Accounting and Financial Disclosure...................13
Item 8A. Controls and Procedures..................................13
Item 8B. Other Information........................................13

PART III

Item 9.  Directors, Executive Officers, Promoters,
         Control Persons and Corporate Governance;
         Compliance with Section 16(a) of the
         Exchange Act.............................................14
Item 10. Executive Compensation...................................15
Item 11. Security Ownership of Certain Beneficial Owners
         and Management and Related Stockholder Matters...........16
Item 12. Certain Relationships and Related
         Transactions, and Director Independence..................17
Item 13. Exhibits.................................................17
Item 14. Principal Accountant Fees and Services...................18

-  Signatures.....................................................18
 -  Section 302 Certification.....................................19
 -  Section 906 Certification.....................................20





















PART I

Special Note Regarding Forward Looking Statements

Certain sections of this annual report contain forward-looking statements.
These statements relate to future events or future financial performance and
involve known and unknown risks, uncertainties and other factors that may
cause the Company's or its industry's actual results, levels of activity,
performance or achievements to be materially different from the future
results, levels of activity, performance or achievements expressed or
implied by the forward-looking statements.

In some cases, you can identify forward-looking statements by words
such as "may," "will," "should," "expects," "plans," "anticipates,"
"believes," "estimates," "predicts," "potential," or the negative of
these terms or other comparable words. These statements are only
predictions. Actual events or results may differ materially.

Although the Company believes that the expectations reflected in the
forward-looking statements are reasonable, it cannot guarantee future
results, levels of activity, performance or achievements. Moreover,
neither the Company nor any person assumes responsibility for the
accuracy and completeness of these forward- looking statements. The
Company is under no duty to update any of the forward-looking statements
after the date of this report to conform its prior statements to actual
results.

ITEM 1. DESCRIPTION OF BUSINESS

BUSINESS OF THE COMPANY.

OVERVIEW. Opt-Sciences Corporation, formed in 1956, conducts its
business through its wholly owned subsidiary, O & S Research, Inc. Both
companies are New Jersey corporations. As used in this form 10-KSB, the
terms "Company", "we" or "our" refer to the combined operations of Opt-
Sciences Corporation and O & S Research, Inc.

Opt-Sciences Corporation, through its wholly owned subsidiary, O & S
Research, Inc., deposits anti-glare and/or transparent conductive optical
coatings on glass used primarily to cover instrument panels in aircraft
cockpits. We also provide full glass cutting, grinding and painting
operations which augment our optical coating capabilities. Most of our
products are designed to enable pilots to read aircraft instruments in direct
sunlight or at night or in covert situations using appropriate night vision
filters. This is a niche business primarily dependent on the needs of new and
used aircraft for initially installed parts, spare parts, replacements and
upgrades. It requires custom manufacturing of small lots of products to
satisfy specific requirements identified by our customers.

The Company's business is highly dependent on a robust commercial, business,
and regional aircraft market; to a lesser degree, it is also dependent on the
military aircraft market. We generally have a four to twelve week delivery
cycle depending on product complexity, available plant capacity and required
lead time for specialty raw materials such as polarizers or filter glass. Our
sales tend to fluctuate from quarter to quarter because all orders are custom
manufactured, and customer orders are generally scheduled for delivery based
on our customer's need date, not on our ability to make shipments. Since the


                                       4

Company has two customers that together represent over 50% of sales, any
significant change in the requirements of either of those customers has a
direct impact on our revenue for any given quarter. When one of these
customers defers a sizable order, sales for the following quarter often
rebound as the customer replenishes its inventory.

Based on our understanding of the industry and the needs of our customers, we
expect to complete and ship approximately 70% of the Fiscal Year 2007
backlog of unshipped orders before the end of the first quarter of fiscal
2008. If we do so, we expect first quarter sales to reach $1,300,000.

Compliance costs are expected to grow this year as more internal controls
are initiated pursuant to regulations promulgated under the
Sarbanes/Oxley Act. We also expect increased costs associated with
marketing and sales as the Company places a greater emphasis on customer
contact.

CORE PRODUCTS. The distinguishing characteristic of our business is our
optical thin film coating capability. Almost all products which we offer
incorporate an optical coating of some type. Our primary coatings are
for aircraft cockpit display applications and consist of our anti-
reflection coating used for glare reduction and our transparent
conductive coating used for electromagnetic interference shielding. We
apply either or both coatings to different types of glass face plates
which are usually mounted on the front of liquid crystal displays (LCDs),
cathode ray tubes (CRTs) and electromechanical displays (EMDs).

ANCILLARY PRODUCTS AND SERVICES. In addition to coated glass described
above, we also offer a full range of other specialty instrument glass,
including night vision filter glass, circular polarizers, touchpads,
glass sandwiches for LCDs as well as other custom designed specialty
glass components and assemblies.

GROWTH STRATEGY. In light of anticipated increased costs associated with
Sarbanes/Oxley compliance in the years ahead, the Company continues to re-
evaluate its growth strategy pertaining to sales and marketing, production
facilities and efficiencies and our staffing methods to maximize the value of
our financial and human resources.

In Fiscal Year 2007, we hired additional production employees in support
of our expanded sales. For Fiscal Year 2008, we expect slightly stronger
commercial and business aircraft markets. We see more potential for growth
in our conductive coating business which is used primarily, but not
exclusively, on military platforms. We expect the anti-reflective coating
market to show only moderate growth since it is used primarily in the
commercial and business avionics sectors. Our future growth is contingent on
increasing our capacity to provide conductive coatings, securing new
customers, developing new products and providing adequate staff and
facilities to meet our needs. We are continuing to look at increasing the
current facility size or moving to a larger facility to accommodate higher
capacity should it be required.

MARKETING AND SALES. Our principal sales executive is our President, who
maintains regular contact with the largest customers and continually
seeks to develop new customers. We do not currently employ the services


                                       5
of manufacturers representatives or sales personnel. O & S Research,
Inc. and our products are listed in the Thomas Register. We also
maintain a sales website at osresearch.comand optsciences.com. We engage
in a low cost public relations and advertising program. Purchasing personnel
of major corporations or governmental agencies place orders with us, based
on price, delivery terms, satisfaction of technical specifications and
quality of product. Procurement departments of customers ordinarily
purchase products from us because we are on an approved vendor list. We
enhance sales prospects by providing creative technical solutions to
customer requirements. We are currently an approved vendor for major
aircraft programs. We continue to be a major supplier for the anti-glare
face plates covering the flat panel displays on the Boeing 777 and the
737 Next Generation models of commercial aircraft, with more of
the display glass being used for the 737s. In 2008, Boeing is projected to
produce approximately 80 777s and 350 737s. We expect that most of
the future growth in overall commercial airplane production
will be from the Boeing 737, 777 and 787. However, Boeing's manufacture of
the 787 is not expected to increase our future revenues because its cockpit
displays will be provided by RockwellCollins, a company that currently
purchases its instrument glass requirements for the 787 from one of our
competitors. In Fiscal 2007, we derived 50% of our revenues from two major
customers, Honeywell Inc.  and TPO Displays Corporation. The loss or
curtailment of business with either of these companies could have
a negative impact on our operating results.

PATENTS, TRADEMARKS AND PROPRIETARY KNOWLEDGE. We do not hold patents or have
registered trademarks. However, our customers do rely on our accumulated
experience and know-how in satisfying their instrument glass requirements.

MANUFACTURING. Our customers commonly use Cathode Ray Tubes and Liquid
Crystal Displays for aircraft cockpit instrumentation. Typically, a customer
sends such items to us for processing. We cut the face plate from large
pieces of glass we purchased from multiple domestic sources on a commodity
basis. We use our technology to apply a micro thin optical non-glare and/or
conductive coating to a face plate, which is then mounted on the Cathode Ray
Tube or Liquid Crystal Display. After quality control tests, we ship the
inspected products to our customers. We also manufacture wedge glass lenses
from large raw glass pieces. The raw glass is a commodity product, which we
can purchase from several glass manufacturers. We cut, grind, polish and coat
the pieces with a micro-thin optical coating. We then ship the lenses to the
customer after clearance through quality control. Both processes utilize the
deposit of a thin film of a metal or metal oxide on the surface of the glass.
The process takes place in a heated vacuum chamber. We heat the deposited
material to over 1800 degrees Centigrade causing it to evaporate. When the
vapor contacts the glass, it condenses forming a very thin film as hard as
the original metal being evaporated. The thin films range in thickness from
250 angstroms to 1500 angstroms.

ENVIRONMENTAL MATTERS. We believe we are in material compliance with
applicable United States, New Jersey and local laws and regulations
relating to the protection of the environment, and we do not devote
material resources to such matters.




                                       6
COMPETITION. Competition is based on product quality, price, reputation
and ability to meet delivery deadlines. The market for our products is very
competitive. The type and amount of instrument glass consumed is subject to
changes in display technology and in ongoing reduction in the number of
displays used on both new aircraft and retrofitted aircraft. Our competitors
include Naugatuck Glass Company, OCLI, Metavac, Mod A Can, Tyrolit, Schott
Glass and Hoya Optics. Our competitors generally have significantly more
financial, technical and human resources than we do. Because of this, our
competitors have the capacity to respond more quickly to emerging
technologies and customer preferences and may devote greater resources to
development, promotion and sale of their products than we can. This
competition could result, and in the past has resulted, in price reductions,
reduced margins and lower market share.

EMPLOYEES. As of October 27, 2007, we employed 47 employees, of which 45
were full time individuals and none of who are members of organized
labor. This represents an increase of 5 full time employees from the end
of Fiscal 2006. We expect to make adjustments to our employee levels
based on changes in the market and our specific efforts to improve
efficiencies and customer service. We believe we have a good relationship
with our employees. We are subject to the federal minimum wage and hour laws
and provide various routine employee benefits such as life and health
insurance. We also provide a 401K Plan for the benefit of all our employees;
we do not have a stock option plan. The 401K Plan includes a matching
contribution from us representing $0.50 for each $1.00 an employee
contributes up to 6% of the employee's base wages.

AVAILABLE INFORMATION. We maintain a website, optsciences.com, where you
may find additional information about our Company. Additional Company
filings are available at the Securities & Exchange Commission's website,
sec.gov. On our website, optsciences.com, we provide links to the SEC, to
Yahoo for the latest stock quotations, to our transfer agent, StockTrans,
and to our manufacturing subsidiary, O & S Research, Inc.

ITEM 2. DESCRIPTION OF PROPERTY

We conduct our operations at the principal office and manufacturing
facility located in the East Riverton Section of Cinnaminson, New Jersey.
We own this 1.4-acre property in fee simple, and the property is not
encumbered by any lien or mortgage. The cinderblock and masonry facility
contains approximately 11,000 square feet of manufacturing space and
approximately 1,200 square feet of office space. We also own and utilize
a building containing 3,000 square feet of warehouse and 5,000 square
feet of manufacturing space on premises adjacent to the main manufacturing
facility. In addition, we lease on a year-to-year basis 5,000 square feet in
Riverton, New Jersey, for general warehouse and material storage.

ITEM 3. LEGAL PROCEEDINGS

We are subject to certain claims and litigation in the ordinary course of
business. It is the opinion of management that the outcome of such matters
will not have a material adverse effect on our combined financial position or
results of operations.







                                       7


ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

None.

PART II

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS
AND SMALL BUSINESS ISSUER PURCHASES OF EQUITY SECURITIES

Our Common Shares are not listed on an established public trading market,
but are quoted by the Pink Sheets, in the non-NASDAQ over the counter
market. The symbol for our Shares is OPST. Only limited and sporadic
trading occurs. Subject to the foregoing qualification, the following
table sets forth the range of bid quotations, for the calendar quarter
indicated, as quoted by Pink Sheets LLC., and reflects inter-dealer prices,
without retail mark up, mark down or commission and may not necessarily
represent actual transactions.

Fiscal 2006               Bid
First Quarter        $6.30 - 6.50
Second Quarter        6.50 - 8.00
Third Quarter         6.25 - 8.00
Fourth Quarter        6.25 - 6.50


Fiscal 2007               Bid
First Quarter        $6.70 -  7.55
Second Quarter        6.80 -  8.60
Third Quarter         6.80 - 10.50
Fourth Quarter        8.85 - 13.00

As of December 31, 2007, the closing bid for the Common Stock was $10.10.
The closing ask price was $13.00. The Company had 924 stockholders of
record of its Common Stock as of December 31, 2007.

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

Opt-Sciences does not have any equity compensation plan in place and did not
issue any equity securities to any person during Fiscal Year 2007.

DISTRIBUTIONS

We did not declare or pay any dividend on our Common Stock during Fiscal
Year 2007 and, although there is no prohibition on payment of dividends, we
do not anticipate the payment of dividends on our Common Stock in the
foreseeable future.

RECENT SALES OF UNREGISTERED SECURITIES

We did not sell unregistered securities during the three fiscal years
ended October 27, 2007.

ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Management's discussion and analysis of financial condition and results of


                                       8
operations are based upon the Company's consolidated financial statements,
which have been prepared in accordance with accounting principles generally
accepted in the United States of America ("U.S. GAAP"). The preparation of
these financial statements requires the Company to make estimates and
judgments that affect the reported amounts of assets, liabilities, revenues
and expenses. The Company bases its estimates on historical experience and on
various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results may differ from these estimates under
different assumptions or conditions. Specifically, inventory is estimated
quarterly and reconciled at the end of the fiscal year when a detailed audit
is conducted (also see Notes to Consolidated Financial Statements, 1. Summary
of Significant Accounting Policies, Note 2. Inventories).

GENERAL

This Management's Discussion and Analysis as of October 27, 2007, should
be read in conjunction with the audited consolidated financial
statements and notes thereto set forth in this report. It may also
contain forward-looking statements as defined in Part I hereof.

LIQUIDITY AND CAPITAL RESOURCES.

We have sufficient liquidity and credit to fund our contemplated capital
and operating activities through Fiscal 2008. We continue to use our working
capital to finance current operations, including equipment purchases, capital
improvements, inventory, payroll and accounts receivable.

Our cash position improved in Fiscal 2007, primarily because of the net
income of $832,761 in Fiscal 2007. Other income also increased over the last
year primarily due to the higher interest rates. Overall, our cash balances
increased during Fiscal 2007 to $6,777,104 from $5,798,506 at the end of
Fiscal 2006.  At the same time, our total current assets increased $1,297,726
from $9,298,048 in Fiscal 2007 from 8,000,322 in Fiscal 2006.

Because of changes in the marketplace and an increasingly competitive
environment, we believe it is necessary to make ongoing investments in
new equipment and processes to compete successfully in the aerospace and
commercial display markets. In Fiscal 2008, we have projected significant
expenditures of capital to update equipment.

RESULTS OF OPERATIONS: FISCAL YEAR 2007

NET SALES
Net sales of $5,712,810 for the Fiscal Year 2007 increased $1,447,414 or
approximately 34% from Fiscal 2006. This large increase in total sales over
last year is due to a significant increase in orders from three of our major
customers for three different reasons. One customer unexpectedly gave us a
contract for the Eclipse 500 very light jet cockpit display glass; another
customer decided to place more business with us instead of their other glass
supplier; and the third customer created a temporary surge in demand as it
migrated from one LCD platform to another.

COST OF SALES
Cost of sales increased $682,443 or 23% for Fiscal 2007 versus Fiscal 2006.
This smaller increase relative to the increase in sales is primarily due to
the Company's continuous improvement initiatives resulting in more efficient
operations and lower scrap rates. Cost of sales is comprised of raw materials,
manufacturing direct labor and overhead expenses. The overhead portion of cost
of sales is primarily comprised of salaries, medical and dental benefits,
building expenses, production supplies, and costs related to our production,
inventory control and quality departments.


                                       9.



OPERATING EXPENSES
Operating expenses for Fiscal 2007 were $923,942, an increase of $140,226 over
Fiscal 2006. Operating expenses include both General and Administrative
expenses and Sales and Delivery expenses. Our General and Administrative
expenses consist of marketing and business development expenses, professional
expenses, salaries and benefits for executive and administrative personnel,
hiring, legal, accounting, and other general corporate expenses.

OPERATING INCOME
Operating income increased $624,745 or 135% to $1,087,707 in Fiscal 2007 from
$462,962 in 2006. The sizable increase over Fiscal 2006 is primarily due to
the significant increase in sales revenue and higher gross margins.

OTHER INCOME
Other income of $314,452 for Fiscal Year 2007 increased from $211,833 for
Fiscal Year 2006. This increase is mainly attributable to higher interest
rates.

NET INCOME
Net income of $832,761 or $1.07 per share for Fiscal 2007 increased from
$404,193 or $.52 per share for Fiscal 2006 as a result of the factors
described above.

BACKLOG OF ORDERS
Our backlog of unshipped orders stood at $2,250,342 at the end of Fiscal
Year 2007, up $946,678 from the end of Fiscal Year 2006 and up $283,395
from the end of the third quarter. We anticipate that the backlog will
fluctuate between $1,500,000 to $2,500,000 in Fiscal 2008, assuming that we
are able to book new business at the rate we are able to deliver products to
our customers. Of the backlog of orders existing at year end, we expect to
deliver 70% within the first quarter of Fiscal Year 2008.  This increase
in backlog reflects a general increase in demand for the Company's aircraft
components.

RESULTS OF OPERATIONS: FISCAL YEAR 2006

Fiscal year 2006 ended with net sales of $4,265,396, a decrease of approxi-
mately $57,800 or 1.3% over Fiscal 2005. The minor decrease in total sales
for 2006 over 2005 was primarilY due to a decline in the demand for wedge
glass products, a continuation of a trend we identified in our earlier
reports. Cost of sales increased $30,857 or 1% for Fiscal 2006 versus Fiscal
2005. General and administrative expenses, including selling expenses, were
$783,716 for Fiscal 2006, an increase of $21,847 over Fiscal 2005. These
expenses were higher in Fiscal 2006 principally because of expenses associ-
ated with Sarbanes/Oxley compliance.


                                       10
Operating income increased $54,349 or 13% to $462,962 in Fiscal 2006 from
$408,613 in 2005. Interest and other income of $211,833 for Fiscal 2006
increased from $137,446 for Fiscal 2005. Net income after tax of $404,193
or $.52 per share for Fiscal 2006 increased from $349,014 or $.45 per share
for Fiscal 2005.

INFLATION

During the three year period that ended on October 27, 2007, inflation
did not have a material effect on our operating results.

OFF BALANCE SHEET ARRANGEMENTS

We do not currently have any off balance sheet arrangements.

COMPANY RISK FACTORS

An investment in our common stock involves investment risks. A
prospective investor should evaluate all information about us and the
risk factors discussed below in relation to his financial circumstances
before investing in us.


                                       11

1. Most of our commercial aircraft display products are for use in Boeing
aircraft. The impact of Boeing's sales on the Company is difficult to
project with a high degree of accuracy. The Boeing 787 scheduled for
delivery in 2008 will utilize proprietary cockpit displays of
RockwellCollins, which currently does not purchase instrument glass from
us for these kinds of displays.

2. The future market for our business aircraft instrument glass presently
appears to be stable. However, the Company has had to hold pricing on
several major product offerings to maintain good customer relations. This
ultimately causes an erosion of profit margins unless more productive and
efficient means of production are implemented.

3. Our product offerings are concentrated. During Fiscal 2007 we derived
95% of our revenues from instrument glass used for avionics and related
aerospace products.

4. Our revenues come from a limited number of customers.

5. For a major portion of our business, we rely on raw materials manu-
factured exclusively in Japan. An interruption of supplies from
Japan would have a significant impact on sales and our ability to support
our customers.

6. Our success depends on the efforts and expertise of our President,
Anderson L. McCabe. He is our chief executive officer, our chief
financial officer and our principal marketing officer. His death,
disability or termination of employment would adversely affect the future
of our Company. We do not have employment contracts with Mr. McCabe or
other management personnel. We do not maintain key man life insurance on
Mr. McCabe or other key personnel.

7. Our future revenues and operating results change from quarter to quarter
due to a number of factors, some of which are adverse, such as:  - Reduced
demand for our avionics related instrument glass; - Aggressive price
competition by our competitors;  - The introduction of alternate display
products that do not utilize our products, such as rear projection displays;
- Overdue deliveries to our customers; and  - Operational plans of our
customers.

8. The market for our products is very competitive.

9. The technology being used for aircraft instruments is changing very
rapidly.  The use of wedge glass displays continues to decline.  Demand for
anti reflective coating on instrument panels is stable, but fewer, larger
panels are commonly used in new and upgraded instrument systems.  We see an
increasing need for conductive coatings on instrument panels, which we hope
will offset the effect of declining sales of coated wedge glass.

10. Our industry is subject to significant risk from outside influences,
such as terrorist attacks (9/11) and biological epidemics (SARs and Avian


                                       12
flu outbreaks in Asia). Other factors that may in the future influence
our industry are inflation, changes in diplomatic and trade relations
with other countries, political and economic stability, tariffs, trade
barriers and other regulatory barriers.

11. Purchase orders from our customers may include extensive product
warranties. Accordingly, warranty claims may have an adverse effect on
our future operating results.

ITEM 7. FINANCIAL STATEMENTS

The Consolidated Financial Statements, the notes thereto, and the reports
thereon by Goff Backa, Alfera & Company, LLC. dated January 21, 2008, are
filed as part of this report starting on page 23 below.

ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE

 None.

ITEM 8A. CONTROLS AND PROCEDURES

(a) Evaluation of disclosure controls and procedures.

Based on an evaluation as of the end of Fiscal Year 2007, our principal
executive officer and principal accounting officer has concluded that our
disclosure controls and procedures (as defined in Rules 13a-14( c ) and
15d-14( c ) under the Securities Exchange Act of 1934 (the "Exchange
Act")) are effective to ensure that information required to be disclosed
by us in reports we file or submit under the Exchange Act is recorded,
processed, summarized and reported within the time periods specified in
Securities and Exchange Commission rules and forms.

(b) Changes in internal controls.

We did not initiate any significant change in our internal controls or
in other factors that could significantly affect these controls
subsequent to the date of their evaluation, including any corrective
action with regard to significant deficiencies and material weaknesses.

ITEM 8B. OTHER INFORMATION.

None.

















                                       13
PART III

ITEM 9. DIRECTORS, EXECUTIVE OFFICERS, PROMOTERS AND CONTROL PERSONS
AND CORPORATE GOVERNANCE; COMPLIANCE WITH SECTION 16(A) OF THE
EXCHANGE ACT

INFORMATION REGARDING EXECUTIVE OFFICERS AND DIRECTORS

Our Directors serve until the next annual meeting of stockholders, or
until their successors have been elected. Our officers serve at the
pleasure of the Board of Directors.

Anderson L. McCabe, 52 years old, is our President, Chief Executive
Officer and Chief Financial Officer. He graduated from the University of
South Carolina in 1977 and received a B.S. in Chemical Engineering. From
1977 to 1985, he was employed by United Engineers and Constructors, Inc.,
a subsidiary of Raytheon Corporation as Process Engineer with managerial
responsibilities. In 1986 he became our president. He has been director
of the Company since 1987.

Arthur J. Kania, 76 years old, is our Secretary.  He is not active in our
day-to-day operations. Mr. Kania's principal occupations during the past
five years have been as Principal of Trikan Associates (real estate
ownership and management - investment firm); and as a partner of the law
firm of Kania, Lindner, Lasak and Feeney. He has been a director of the
Company since 1977.

Arthur J. Kania, Jr., 52 years old, has been a director of the Company
since 1987. He is not active in our day-to-day operations. He is a principal
of Trikan Associates (real estate ownership and management-investment firm)
and vice-president of Newtown Street Road Associates (real estate ownership
and management).

SECTION 16(A)   BENEFICIAL OWNERSHIP REPORTING COMPLIANCE.

Section 16(a) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), requires the Company's officers, directors and any
person owning ten percent or more of the Company's common stock, to file
in their personal capacities initial statements of beneficial ownership,
statements of change in beneficial ownership and annual statements of
beneficial ownership with the Securities and Exchange Commission (the
"SEC"). Persons filing such beneficial ownership arrangements are
required by SEC regulation to furnish to the Company copies of all such
statements filed with the SEC. The rules of the SEC regarding the filing
of such statements require that "late filings" of such statements be
disclosed in the Company's information statement. Based solely on the
Company's review of copies of such statements received by, and on
representations from, the Company's existing directors and officers that
no annual statements of beneficial ownership were required to be filed by
such persons, the Company believes that all such statements were timely
filed in 2007.

BOARD MEETINGS AND COMMITTEES

Audit Committee and Audit Committee Financial Expert

Our Board of Directors functions as an audit committee and performs some
of the same functions as an audit committee including: (1) selection and
oversight of our independent accountant; (2) establishing procedures
for the receipt, retention and treatment of complaints regarding


                                       14
accounting, internal controls and auditing matters; and (3) engaging
outside advisors. We are not a "listed company" under SEC rules and are
therefore not required to have an audit committee comprised of independent
directors. Our Board of Directors does not have an independent director. Our
Board of Directors has determined that each of its members is able to read
and understand fundamental financial statements and has substantial relevant
business and accounting experience. Accordingly, the Board of Directors
believes that each of its members has sufficient knowledge and
experience necessary to fulfill the duties and obligations that an audit
committee would have.

Board Meetings; Nominating and Compensation Committees

Our directors and officers do not receive remuneration from us unless
approved by the Board of Directors or pursuant to an employment
contract. We do not have any employment contract currently in place.
We pay each of our Directors a fixed annual stipend for acting as Director.
No such payment shall preclude any director from serving us in any other
capacity and receiving compensation therefore. A total of $7,500 has been
paid to each director for services as director during the last fiscal year.

We are not a "listed company" under SEC rules and are therefore not
required to have a compensation committee or a nominating committee. We
do not currently have a compensation committee. Our Board of Directors
is currently comprised of only three members, one of whom acts as Chief
Executive Officer and Chief Financial Officer.


ITEM 10.     EXECUTIVE COMPENSATION
The following table sets forth certain summary information concerning
compensation paid or accrued to its sole executive officer during the past
three fiscal years.


SUMMARY COMPENSATION

SUMMARY COMPENSATION

              Annual Compensation                         Long Term Compensation
                                                            Awards     Pay-outs

  (a)        (b)    (c)     (d)     (e)       (f)      (g)     (h)      (i)

Name       Fiscal  Salary  Bonus   Other   Restricted Options/ LTIP    All
And        Year    (1)($)  ($)     Annual  Stock      SARs     Pay-    Other
Principal                          Compen- Award(s)   (#)(1)   Outs($) Compen-
Positions                          sation) ($)(1)                      sation
                                    ($)                                 ($)

Anderson   2007   $118,750 25,000  7,500*    -         -        -        -
L. McCabe  2006   $93,750  25,000  5,000*    -         -        -        -
President, 2005   $75,000  15,000  2,500*    -         -        -        -
CEO, CFO
Treasurer
and
Director
                     *Annual retainer as Director of Company


                                       15

DIRECTOR COMPENSATION FOR 2007 FISCAL YEAR
Cash Compensation
Name                  Annual Retainer Meeting Fees Consulting Fees Other Fees

Anderson L. McCabe      $7,500          $0                 $0         $0
Arthur J. Kania*        $7,500          $0                 $0         $0
Arthur J. Kania, Jr.    $7,500          $0                 $0         $0
*  See Certain Transactions and Relationships below.

OPTION/SAR GRANTS; DEFERRED EXECUTIVE COMPENSATION PLAN; EQUITY COMPENSATION
PLAN

The Company did not grant stock options or stock appreciation rights
during Fiscal Year 2007, nor does it have any of such rights outstanding
from prior years. The Company does not have any deferred executive
compensation plan.  The Company does not have any securities authorized for
issuance under an equity compensation plan.

CODE OF ETHICS

The Company's Code of Ethics is posted at its website at optsciences.com. It
applies to all employees, including the CEO, CFO, principal accounting
officer and persons performing similar functions.

ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or
investment power with respect to securities. The following table sets
forth common stock ownership information as of the record date with
respect to (i)each person known to us to be the beneficial owner of more
than 5% of our issued and outstanding common stock;(ii)each of our
directors and executive officers.

Name and Address of                Amount and Nature of    Percent of
Beneficial Owner                   Beneficial Owner        Class

Arthur John Kania Trust 3/30/67           510,853           66%
Rose Sayen, Trustee
Suite 525, Two Bala Plaza
333 City Avenue
Bala Cynwyd, PA 19004

Security Ownership of Directors and Officers:

Name and Address of                Amount and Nature of    Percent of
Beneficial Owner                   Beneficial Owner        Class

Anderson L. McCabe                          1,064(1)          *
P.O. Box 221
1912 Bannard Street
Riverton, N.J. 08077

Arthur J. Kania                            23,723(1)          3%
Suite 525, Two Bala Plaza
Bala Cynwyd, PA 19004



                                       16
Arthur J. Kania, Jr.                            0(1)          *
Suite 525, Two Bala Plaza
Bala Cynwyd, PA 19004

Directors and Officers As a Group          24,787(1)          3%
*Less than 1% of the outstanding Common Stock

1.  Excludes 510,853 shares (66% of the outstanding shares) owned by a trust
for the benefit of Arthur J. Kania's children and a total of 10,000 shares
(1.3% of the outstanding shares) owned by separate trusts for the benefit of
each of Arthur J. Kania's grandchildren. Mr. Kania has no voting power or
investment power with respect to such securities and disclaims beneficial
ownership in all such shares. Mr. McCabe, husband of a beneficiary of the
trust, disclaims beneficial ownership in all such shares. Arthur J. Kania,
Jr., a son of Arthur J. Kania, is a beneficiary of the first aforementioned
trust and father of beneficiaries of the second aforementioned trusts, but
has no voting power and no investment power over such shares in said trusts
and is not a beneficial owner under the applicable rules.

ITEM 12. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE

Arthur J. Kania is the father of Arthur J. Kania, Jr. and the father-in-
law of Anderson L. McCabe. Those individuals constitute the Board of
Directors. Anderson L. McCabe is the sole executive officer. Rose Sayen,
an employee of Arthur J. Kania, is the Trustee of the Arthur J. Kania
Trust, which is the principal shareholder of the Company.

During Fiscal year 2007, we incurred legal fees of $40,500 to the firm
Of Kania, Lindner, Lasak and Feeney, of which Arthur J. Kania is the
Senior partner. Mr. Kania does not share or participate in fees generated
from the Company.

ITEM 13. EXHIBITS

The following exhibits are incorporated by reference or included as part of
this report:

Exhibit Number  Description

3.1; 3.2  Articles of Incorporation and By-Laws incorporated by reference to
   the Form 10-KSB filed by the Registrant with the SEC on February 10, 1998
   for its fiscal year ended November 1, 1997 starting on page 22.

21. List of Subsidiaries incorporated by reference to the Form 10-KSB filed
    by the Registrant with the SEC on February 10, 1998 for its fiscal year
    ended November 1, 1997 starting on page 54.

31. Certification pursuant Section 302 of the Sarbanes Oxley Act included as
    an exhibit to this Form 10KSB.




                                       17
32. Certification pursuant to Section 906 of the Sarbanes Oxley Act included
   as an exhibit to this Form 10KSB.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

    Type                        2006                2007
Audit Fees:                   $26,682             $28,468
Audit Related Fees:                $0                  $0
Tax Fees                           $0                  $0
Other Fees                         $0                  $0
  Total Fees                  $26,682             $28,468

(1) AUDIT FEES
This category includes the aggregate fees billed or accrued for each of the
last two fiscal years for professional services rendered by the independent
auditors for the audit of the Company's annual financial statements and
review of financial statements included in the Company's Form 10-KSB  or 10-
QSB  or services that are normally provided by the accountant in connection
with statutory and regulatory filings or engagements for those fiscal years

(2) AUDIT-RELATED FEES
This category includes the aggregate fees billed in each of the last two
fiscal years for services by the independent auditors that are reasonably
related to the performance of the audits of the financial statements and are
not reported above under "Audit Fees."

(3) TAX FEES
This category includes the aggregate fees billed in each of the last two
years for professional services rendered by the independent auditors for tax
compliance, tax planning and tax advice.

(4) ALL OTHER FEES
This category includes the aggregate fees billed in each of the last two
fiscal years for products and services by the independent auditors that are
not reported under "Audit Fees" "Audit Related Fees", or "Tax Fees."

RE-APPROVAL POLICIES AND PROCEDURES

Before the accountant is engaged by the issuer to render audit or non-
audit services, the engagement is approved by the Company's Board of
Directors acting as the audit committee.

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange
Act, the registrant has caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

OPT-SCIENCES CORPORATION

 By
        Anderson L. McCabe, President

        Date: January 25, 2008




                                       18

In accordance with the Exchange Act, this report has been signed below by the
following persons on behalf of the registrant and in the capacities and on
the dates indicated.

SIGNATURE                   TITLE                     DATE

Anderson L. McCabe          President,           January 25, 2008
                            CEO, CFO
                            and Director


Arthur J. Kania             Secretary            January 25, 2008
                            and
                            Director
Arthur J. Kania, Jr.        Director             January 25, 2008


Lorraine Domask             Chief Accountant     January 25, 2008


SECTION 302 CERTIFICATION

I, Anderson L. McCabe, President, Chief Executive Officer and Chief
Financial Officer, certify that:

1. I have reviewed this annual report on Form 10-KSB of OPT-SCIENCES
CORPORATION;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this annual report;


3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all
material respects the financial condition, results of operations and cash
flows of the registrant as of, and for, the periods presented in this
report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and
have:

a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is
being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the
period covered by this report based on such evaluation; and


                                       19
c) Disclosed in this report any change in the registrant's internal control
over financial reporting that occurred during the registrant's most recent
fiscal quarter (that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial
reporting; and ;

5. The registrant's other certifying officer(s) and I have disclosed,
based on our most recent evaluation o internal control of financial
reporting, to the registrant's auditors and the audit committee of
registrant's board of directors (or person performing the equivalent
functions):

   a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

   b) Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's internal
control over financial reporting.


Date: January 25, 2008

 /s/Anderson L. McCabe

Anderson L. McCabe President, Chief Executive Officer and Chief Financial
Officer




SECTION 906 CERTIFICATION

I, Anderson L. McCabe, Chief Executive Officer and Chief Financial
Officer of OPT-SCIENCES CORPORATION (the "Company"), certify, pursuant to
section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350,
that:

(1) the Annual Report on Form 10KSB of the Company for the fiscal year
ended October 27, 2007 (the "Report) fully complies with the requirements
of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15
U.S.C. 78m or 78o(d); and (2) the information contained in the Report
fairly presents, in all material respects, the financial condition and
results of operations of the Company.

Dated: January 25, 2008

                           By:/s/Anderson L. McCabe,
                    Chief Executive Officer and Chief Financial Officer










                                       20
















                               OPT - Sciences Corporation
                                    And Subsidiary

                                 Financial Statements

                            Years Ended October 27, 2007
                                 And October 28, 2006





































                                       21



                               TABLE OF CONTENTS

                                                                      PAGE

Report of Independent Registered Public Accounting Firm ................23

Consolidated Balance Sheets.............................................24

Consolidated Statements of Operations...................................26

Consolidated Statements of Stockholders' Equity and Comprehensive
Income..................................................................27

Consolidated Statements of Cash Flow....................................28

Notes to Consolidated Financial Statements..............................30









































                                       22

Report of Independent Registered Public Accounting Firm


To Stockholders and Board of Directors
OPT-Sciences Corporation

We have audited the accompanying consolidated balance sheets
of OPT-Sciences Corporation and Subsidiary as of October 27, 2007 and
October 28, 2006 and the related statements of operations,
stockholders' equity and comprehensive income and cash flows for each
of the fiscal years in the two-year period ended October 27, 2007.
These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these
financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public
Company Accounting Oversight Board (United States). Those standards
require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement. The company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting.
Our audit included consideration of internal control over financial
reporting as a basis for designing audit procedures that are
appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the company's internal
control over financial reporting. Accordingly, we express no opinion.
An audit also includes examining, on a test basis, evidence supporting
the amounts and disclosures in the financial statements, assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis
for our opinion.

In our opinion, the financial statements referred to above present
fairly, in all material respects, the consolidated financial position
of OPT-Sciences Corporation and Subsidiary as of October 27, 2007 and
October 28, 2006 and the consolidated results of their operations and
their cash flows for each of the fiscal years in the two-year period
ended October 27, 2007 in conformity with U.S. generally accepted
accounting principles.



Goff, Backa, Alfera & Company, LLC
Pittsburgh, Pennsylvania

January 21, 2008












                                       23
                       Opt-Sciences Corporation
                      Consolidated Balance Sheets
The accompanying notes are an integral part of these financial statements

                                  ASSETS

                                   October 27,    October 28,
                                       2007           2006
CURRENT ASSETS

Cash and cash equivalents           $6,777,104  $ 5,798,506
Trade accounts receivable            1,012,659      811,369
Inventories                            592,660      569,967
Prepaid expenses                        21,074       39,578
Prepaid income taxes                       -0-       23,900
Loans and exchanges                      4,390        3,505
Deferred income taxes                      -0-        3,070
Marketable securities                  890,161      750,427

  Total current assets               9,298,048    8,000,322

PROPERTY AND EQUIPMENT

Land                                   114,006      114,006
Building and improvements              449,987      449,987
Machinery and equipment              1,485,573    1,415,709
Small tools                             53,580       53,580
Furniture and fixtures                   8,624        8,624
Office equipment                        57,419       52,148
Automobiles                             71,211       85,605

  Total property and
   equipment                         2,240,400    2,179,659

Less: accumulated depreciation       1,652,891    1,551,421

    Net property and
     equipment                         587,509      628,238

OTHER ASSETS

Deposits                                 2,837        2,837

   Total assets                    $ 9,888,394  $ 8,631,397
















                                       24
                         Opt-Sciences Corporation
                        Consolidated Balance Sheets
The accompanying notes are an integral part of these financial statements

                     LIABILITIES AND STOCKHOLDERS' EQUITY

                                          October 27,   October 28,
                                              2007        2006
CURRENT LIABILITIES

Accounts payable - trade                   $  86,759   $  83,621
Accrued income taxes                         267,980         -0-
Deferred income taxes                         30,100         -0-
Other current liabilities                    338,823     225,203

 Total current liabilities                   723,662     308,824


STOCKHOLDERS' EQUITY

Common capital stock - par value
$.25 per share - authorized
and issued 1,000,000 shares                  250,000     250,000
Additional paid in capital                   272,695     272,695
Retained earnings                          8,810,376   7,977,615
Accumulated other comprehensive income:
Unrealized holding gain (loss)
on marketable securities                      18,879       9,481
Less treasury stock at cost -
224,415 shares                              (187,218)   (187,218)


 Total stockholders' equity                9,164,732   8,322,573

   Total liabilities and
    stockholders' equity                  $9,888,394  $8,631,397

























                                       25

                     Opt-Sciences Corporation
               Consolidated Statements of Operations
The accompanying notes are an integral part of these financial statements

                                 Fiscal Year Ended   Fiscal Year Ended
                                 October 27, 2007    October 28, 2006
                                    (52 weeks)           (52 weeks)

NET SALES                           $ 5,712,810        $ 4,265,396

COST OF SALES                         3,701,161          3,018,718

Gross profit on sales                 2,011,649          1,246,678

OPERATING EXPENSES

Sales & delivery                         46,427             60,739
General and administrative              877,515            722,977

  Total operating expenses              923,942            783,716

 Operating income                     1,087,707            462,962

OTHER INCOME                            314,452            211,833

Income before taxes                   1,402,159            674,795

FEDERAL AND STATE
INCOME TAXES                            569,398            270,602

Net income                              832,761            404,193

EARNINGS PER SHARE OF
COMMON STOCK                               1.07               0.52

Weighted average number
of shares                               775,585            775,585





















                                       26

                             Opt-Sciences Corporation
    CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE INCOME
   The accompanying notes are an integral part of these financial statements

                                            Accumulated
                                               Other
                                              Compre-
                  Common  Paid-in  Retained   hensive   Treasury
                  Stock   Capital  Earnings   Income      Stock     Total

BALANCE
OCTOBER 29,
2005             $250,000 $272,695 $7,573,422 $(32,202) $(187,218) $7,876,697

Net income
for fiscal
year ended
October 28,
2006                                  404,193                         404,193

Unrealized
holding gains
on securities
arising during
period, net of
tax of $31,445                                  41,683                 41,683

TOTAL COMPREHENSIVE INCOME                                            445,876

BALANCE
OCTOBER 28,
2006             $250,000 $272,695 $7,977,615 $  9,481  $(187,218) $8,322,573

Net income for
fiscal year
ended
October 27,
2007                                  832,761                         832,761

Unrealized
holding gains
on securities
arising during
period, net of
tax of
$7,089                                           9,398                  9,398

TOTAL COMPREHENSIVE INCOME                                            842,159

BALANCE
OCTOBER 27,
2007             $250,000 $272,695 $8,810,376 $ 18,879  $(187,218) $9,164,732






                                       27

                       Opt-Sciences Corporation
                    CONSOLIDATED STATEMENTS OF CASH FLOWS
The accompanying notes are an integral part of these financial statements


                                 Fiscal Year Ended    Fiscal Year Ended
                                 October 27, 2007     October 28, 2006
                                     (52 weeks)           (52 weeks)

CASH FLOWS FROM OPERATING ACTIVITIES

Net income                              832,761              404,193

Adjustments to reconcile net income
to net cash (used) provided by
operating activities:

Depreciation                            115,864              118,719
(Gain) loss on sale of securities       (33,721)              21,363
Deferred income taxes                    26,080                1,659

Decrease (increase) in:
Accounts receivable                    (201,290)            (224,341)
Inventories                             (22,693)            (171,904)
Prepaid expenses                         18,504              (10,863)
Prepaid income taxes                     23,900              (23,900)
Loans and exchanges                        (885)               1,123

(Decrease) increase in:
Accounts payable                          3,138               21,170
Accrued income taxes                    267,980             (231,141)
Other current liabilities               113,620                6,095

  Net cash provided (used)
   by operating activities            1,143,258              (87,827)

CASH FLOWS FROM INVESTING ACTIVITIES

Purchases of property and equipment     (75,135)             (44,354)
Purchases of securities                (500,606)            (154,474)
Proceeds from sale of securities        411,081              728,933

  Net cash (used) provided
   by investing activities             (164,660)             530,105












                                       28

                  Opt-Sciences Corporation
                CONSOLIDATED STATEMENTS OF CASH FLOWS
The accompanying notes are an integral part of these financial statements


                                 Fiscal Year Ended    Fiscal Year Ended
                                 October 27, 2007     October 28, 2006
                                   (52 weeks)            (52 weeks)

Increase in cash                    $   978,598          $   442,278

Cash and cash equivalents
  at beginning of year                5,798,506            5,356,228

Cash and cash equivalents
  at end of period                  $ 6,777,104          $ 5,798,506

SUPPLEMENTAL DISCLOSURES:

Interest paid                       $     3,550          $       571

Income taxes paid                   $   251,438          $   525,262





































                                       29

                  OPT-Sciences Corporation and Subsidiary
                 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of OPT-
Sciences Corporation and its wholly owned subsidiary. All significant
inter-company accounts and transactions have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the
date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. Actual results could differ
from those estimates.

Cash and Cash Equivalents

The Company considers certificates of deposit and debt securities
purchased with a maturity of three months or less to be cash
equivalents.

Line of Business and Credit Concentration

The Company, through its wholly owned subsidiary, is engaged in the
business of applying anti reflective, conductive and/or other coatings
to the faceplates of instruments for aircraft cockpits. The Company
grants credit to companies within the aerospace industry.

Accounts Receivable

Bad debts are charged to operations in the year in which the account is
determined to be uncollectible. If the allowance method for doubtful
accounts were used it would not have a material effect on the financial
statements.

Inventories

Raw materials are stated at the lower of average cost or market. Work
in process and finished goods are stated at accumulated cost of raw
material, labor and overhead, or market, whichever is lower. Market is
net realizable value.












                                       30

                     OPT-Sciences Corporation and Subsidiary
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


Marketable Securities

Marketable securities consist of debt and equity securities and mutual
funds. Equity securities include both common and preferred stock.

The Company's investment securities are classified as "available-for-
sale". Accordingly, unrealized gains and losses and the related
deferred income tax effects when material, are excluded from earnings
and reported as a separate component of stockholders' equity as
accumulated other comprehensive income. Realized gains or losses are
computed based on specific identification of the securities sold.

Property and Equipment

Property and equipment are comprised of land, building and improvements,
machinery and equipment, small tools, furniture and fixtures, office
equipment and automobiles. These assets are recorded at cost.

Depreciation for financial statement purposes is calculated over
estimated useful lives of three to twenty-five years, using the straight-
line method.

Maintenance and repairs are charged to expense as incurred.

Income Taxes

Deferred income taxes reflect the net tax effects of temporary
differences between the carrying amounts of assets and liabilities for
financial reporting purposes and the amounts used for income tax
purposes.

Employee Benefit Plans

On October 1, 1998, the Company implemented a 401(k) profit sharing plan.
All eligible employees of the Company are covered by the Plan. Company
contributions are voluntary and at the discretion of the Board of
Directors. Company contributions were $27,069 and $26,093 for the years
ended October 27, 2007 and October 28, 2006, respectively.

Earnings per Common Share

Earnings per common share were computed by dividing net income by the
weighted average number of common shares outstanding.












                                       31

                 OPT-Sciences Corporation and Subsidiary
               NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 - Inventories

Inventories consisted of the
following:
                                            October 27,     October 28,
                                              2007             2006

Raw materials and supplies                 $  215,935     $  226,048
Work in progress                              332,089        305,974
Finished goods                                 44,636         37,945


                                           $  592,660     $  569,967

NOTE 3- Marketable Securities

                                     Gross         Gross
                      Amortized    Unrealized    Unrealized    Fair
                         Cost        Gains          Losses     Value

October 27, 2007
 Common stock         $ 266,708     $ 40,639     $     -0-   $ 307,347
 Preferred stock        112,567          -0-       (10,747)    101,820
 Municipal bonds         82,244          -0-        (5,767)     76,477
 Mutual funds           395,521        8,996           -0-     404,517

                      $ 857,040     $ 49,635     $ (16,514)  $ 890,161

October 28, 2006
 Common stock         $ 221,069     $ 55,974     $     -0-   $ 277,043
 Preferred stock        112,567          -0-          (592)    111,975
 Municipal bonds         82,244          -0-        (5,072)     77,172
 Mutual funds           317,914          -0-       (33,677)    284,237

                      $ 733,794     $ 55,974     $ (39,341)  $ 750,427

Sales of securities available for sale during the years ended October 27,
2007 and October 28, 2006 were as follows:

                                       2007            2006

Proceeds from sales                $ 411,081       $ 728,933

Gross realized gains               $  81,116       $  16,140

Gross realized losses              $  47,39        $  37,503










                                       32

            OPT-Sciences Corporation and Subsidiary
            NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



NOTE 4 - Income Taxes

The income tax expense of the Company consists of the following:

                                    2007               2006
Current tax expense:

 Federal                        $  412,054          $ 208,702

 State                             131,264             60,241

 Total                             543,318            268,943

Deferred tax expense:

 Federal                            21,825              1,330

 State                               4,255                329

 Total                              26,080              1,659

Income Tax Expense              $  569,398          $ 270,602

At October 27, 2007, the Company had a deferred tax asset of $57,758 and a
deferred tax liability of $87,858, resulting in a net deferred tax liability
of $30,100.

At October 28, 2006 the Company had a deferred tax asset of $84,340 and a
deferred tax liability of $81,270, resulting in a net deferred tax asset of
$3,070.


Deferred income taxes result from significant temporary differences between
income for financial reporting purposes and taxable income. These
differences arose principally from the use of accelerated tax depreciation
and the carry forward of capital and net operating losses.

At October 27, 2007, the Company had capital loss carry forwards of $85,745
expiring in 2007 through 2010. Of these losses, an amount equal to $27,985
after application of current year capital gains of $33,721 is deemed to be
usable before expiration.

NOTE 5 - Major Customers

Two customers accounted for $2,889,796 of net sales during the year ended
October 27, 2007. The amount due from these customers, included in trade
accounts receivable, was $579,564 on October 27, 2007.







                                       33

OPT-Sciences Corporation and Subsidiary
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Two customers accounted for $2,241,853 of net sales during the year ended
October 28, 2006. The amount due from these customers, included in trade
accounts receivable, was $504,554 on October 28, 2006.

NOTE 6 - Concentration of Credit Risk of Financial Instruments

The Company has various demand and time deposits with financial institutions
where the amount of the deposits exceeds the federal insurance limits of the
institution on such deposits. The maximum amount of accounting loss that
would be incurred if an individual or group that makes up the concentration
of the deposits failed completely to perform according to the terms of the
deposit was $6,300,000 on October 27, 2007.

NOTE 7 - Related Party Transactions

During fiscal years 2007 and 2006, the Company incurred legal fees of $40,500
and $37,500, respectively to the firm of Kania, Lindner, Lasak and Feeney, of
which Mr. Arthur Kania, a shareholder and director, is senior partner. Of
the legal fees, $40,500 and $37,500 were included in accounts payable at
October 27, 2007 and October 28, 2006, respectively.